NCT07098793Completed
Cough Monitoring in COPD
Cough Monitoring in COPD:a Mixed Methods Observational Study
Source: ClinicalTrials.gov · Last updated 1 Aug 2025
Brief summary (registry, in English)
This is an observational study designed to learn about symptoms of cough and how changes in cough may be associated with the beginning of a COPD exacerbation (acute worsening of symptoms. The Investigators are looking to recruit patients diagnosed with COPD who have had two or more exacerbations of their disease within the last year requiring treatment with antibiotics or corticosteroids. The main question aimed to be answered is whether the cough monitor can detect changes in a patient's clinical condition. Patients will be screened for participation in the study and a medical history will be taken alongside details of current medications, height, weight, vital signs as well and smoking status. The patients will be asked to complete 3 questionnaires and the cough monitor will be installed in the room within their home where they sleep. Patients will be asked to complete a daily diary for 90 to a maximum of 180 days and leave the monitor recording cough throughout this time.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 39 (actual)
- First submitted
- 5 Sept 2023
- Start date
- 18 May 2022
- Primary completion date
- 19 Jun 2024
- Lead sponsor
- Hull University Teaching Hospitals NHS Trust
- Diseases
- COPD
- NCT number
- NCT07098793
What you commit to
- Study type: Observational
- Participants enrolled: 39
- From 18 May 2022 to the primary completion date, 19 Jun 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Age
- • Children \< age of 18
- Failure to provide consent
- Other significant comorbid medical or psychological condition that is deemed by the principal investigator to affect cough frequency or the subject's ability to comply with monitoring procedures.
Who the study is looking for
- • Clinical diagnosis of COPD using GOLD criteria.
- 2 or more moderate and/or severe exacerbations of COPD in the previous year\*.
- Clinical stability (i.e. absence of exacerbation requiring oral corticosteroids and/or antibiotics) for at least 4 weeks prior to enrollment.
- Current or ex-smoker with ≥10 pack-year smoking history
- Provision of informed consent
Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Redspiratory mMedicine, First Floor, Daisy Building, Castle Hill Hospital Coordinator of this site? Confirm its status | Cottingham | United Kingdom | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.